Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2015

01-12-2015 | Original Article

A retrospective analysis of oesophageal thickening diagnosed as an incidental finding at Computed Tomography with endoscopic and histological correlation

Authors: U. Salati, K. Courtney, H. K. Kok, W. Torreggiani

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Purpose

A retrospective analysis of oesophageal thickening diagnosed as an incidental finding at Computed Tomography (CT) with endoscopic and histological correlation.

Materials and methods

Retrospective review of CT studies at a University Teaching Hospital in a 3-month period was performed and those who had a correlating upper gastrointestinal endoscopy within 6 months of the CT were included in the study. The findings were correlated with results from endoscopy to histology. The CT images were reviewed by two Consultant Radiologists with a sub-speciality interest in Abdominal Imaging prior to correlation with endoscopic and histology results from the patient’s medical records.

Results

Three hundred and sixty-one patients met the inclusion, of which 20 % (n = 72) were felt to have a thickened distal oesophagus on CT. Of these, 30.6 % (n = 22) had a mass or abnormal mucosal thickening on endoscopy, found to be malignant on subsequent biopsy in 50 % (n = 11) and Barrett’s epithelium in 50 % (n = 11), a statistically significant finding compared to those who had a normal CT.

Conclusion

Endoscopic evaluation is recommended for incidental oesophageal thickening detected at Computed Tomography to exclude underlying malignancy.
Literature
1.
go back to reference Xia F, Mao J, Ding J, Yang H (2009) Observation of normal appearance and wall thickness of oesophagus on CT images. Eur J Radiol 72(3):406–411CrossRefPubMed Xia F, Mao J, Ding J, Yang H (2009) Observation of normal appearance and wall thickness of oesophagus on CT images. Eur J Radiol 72(3):406–411CrossRefPubMed
2.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed
3.
go back to reference Siegel R, Naishadham D, Jemal A (2012) Cancer statistics for Hispanics/Latinos, 2012. CA-Cancer J Clin 62(5):283–298CrossRefPubMed Siegel R, Naishadham D, Jemal A (2012) Cancer statistics for Hispanics/Latinos, 2012. CA-Cancer J Clin 62(5):283–298CrossRefPubMed
4.
go back to reference Umeoka S, Koyama T, Togashi K et al (2006) Oesophageal cancer: evaluation with triple-phase dynamic CT–initial experience. Radiology 239(3):777–783CrossRefPubMed Umeoka S, Koyama T, Togashi K et al (2006) Oesophageal cancer: evaluation with triple-phase dynamic CT–initial experience. Radiology 239(3):777–783CrossRefPubMed
5.
go back to reference Kim SH, Kim YJ, Lee JM et al (2007) Oesophageal varices in patients with cirrhosis: multidetector CT esophagography–comparison with endoscopy. Radiology 242(3):759–768CrossRefPubMed Kim SH, Kim YJ, Lee JM et al (2007) Oesophageal varices in patients with cirrhosis: multidetector CT esophagography–comparison with endoscopy. Radiology 242(3):759–768CrossRefPubMed
6.
go back to reference Kim YJ, Raman SS, Yu NC, To’o KJ, Jutabha R, Lu DS (2007) Oesophageal varices in cirrhotic patients: evaluation with liver CT. Am J Roentgenol 188(1):139–144CrossRef Kim YJ, Raman SS, Yu NC, To’o KJ, Jutabha R, Lu DS (2007) Oesophageal varices in cirrhotic patients: evaluation with liver CT. Am J Roentgenol 188(1):139–144CrossRef
7.
go back to reference Berkovich GY, Levine MS, Miller WT Jr (2000) CT findings in patients with esophagitis. Am J Roentgenol 175(5):1431–1434CrossRef Berkovich GY, Levine MS, Miller WT Jr (2000) CT findings in patients with esophagitis. Am J Roentgenol 175(5):1431–1434CrossRef
8.
go back to reference Gill KR, Ghabril MS, Jamil LH et al (2010) Variation in Barrett’s oesophageal wall thickness: is it associated with histology or segment length? J Clin Gastroenterol 44(6):411–415CrossRefPubMed Gill KR, Ghabril MS, Jamil LH et al (2010) Variation in Barrett’s oesophageal wall thickness: is it associated with histology or segment length? J Clin Gastroenterol 44(6):411–415CrossRefPubMed
9.
go back to reference Weston AP, Badr AS, Hassanein RS (1999) Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94(12):3413–3419CrossRefPubMed Weston AP, Badr AS, Hassanein RS (1999) Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94(12):3413–3419CrossRefPubMed
10.
go back to reference Cameron AJ (1999) Barrett’s oesophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 94(8):2054–2059CrossRefPubMed Cameron AJ (1999) Barrett’s oesophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 94(8):2054–2059CrossRefPubMed
Metadata
Title
A retrospective analysis of oesophageal thickening diagnosed as an incidental finding at Computed Tomography with endoscopic and histological correlation
Authors
U. Salati
K. Courtney
H. K. Kok
W. Torreggiani
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1213-1

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine